{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T09:17:03Z","timestamp":1787995023456,"version":"build-2784847793"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10067-026-08271-z","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T22:15:40Z","timestamp":1783721740000},"page":"5491-5501","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Disease-modifying anti-rheumatic drugs and systemic glucocorticoid use and risk of vertebral fractures in axial spondyloarthropathies: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6062-0138","authenticated-orcid":false,"given":"Somayeh","family":"Soroureddin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Baradaran Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepehr","family":"Aghajanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Javad","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fateme","family":"Mohammadifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"issue":"10","key":"8271_CR1","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41584-025-01286-x","volume":"21","author":"JD Reveille","year":"2025","unstructured":"Reveille JD, Eder L, Ziade N, Sampaio-Barros PD, Kim T-H, Akko\u00e7 N, Brown MA (2025) Global epidemiology of spondyloarthritis. Nat Rev Rheumatol 21(10):580\u2013598","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"8271_CR2","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1136\/ard-2023-225185","volume":"83","author":"D van der Heijde","year":"2024","unstructured":"van der Heijde D, Molto A, Ramiro S, Braun J, Dougados M, van Gaalen FA et al (2024) Goodbye to the term \u2018ankylosing spondylitis\u2019, hello \u2018axial spondyloarthritis\u2019: time to embrace the ASAS-defined nomenclature. Ann Rheum Dis 83(5):547\u2013549","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"8271_CR3","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1093\/rheumatology\/key027","volume":"57","author":"KY Kang","year":"2018","unstructured":"Kang KY, Kim IJ, Park S-H, Hong YS (2018) Associations between trabecular bone score and vertebral fractures in patients with axial spondyloarthritis. Rheumatology 57(6):1033\u20131040","journal-title":"Rheumatology"},{"issue":"1","key":"8271_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-025-09088-8","volume":"26","author":"C Ceolin","year":"2025","unstructured":"Ceolin C, Bindoli S, Cozzi G, di Marzio B, Lorenzin M, De Rui M et al (2025) Body composition, bone mineral density, and functional impairment in axial spondyloarthritis: a 36-month longitudinal study. BMC Musculoskelet Disord 26(1):878","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"8271_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.semarthrit.2017.12.001","volume":"48","author":"J Ram\u00edrez","year":"2018","unstructured":"Ram\u00edrez J, Nieto-Gonz\u00e1lez JC, Curbelo Rodr\u00edguez R, Casta\u00f1eda S, Carmona L (2018) Prevalence and risk factors for osteoporosis and fractures in axial spondyloarthritis: a systematic review and meta-analysis. Semin Arthritis Rheum 48(1):44\u201352","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"8271_CR6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.medcli.2022.10.013","volume":"160","author":"K Sharif","year":"2023","unstructured":"Sharif K, Tsur AM, Ben-Shabat N, Watad A, Cohen AD, Amital H (2023) The risk of osteoporosis in patients with ankylosing spondylitis-a large retrospective matched cohort study. Med Clin (Barc) 160(9):373\u2013378","journal-title":"Med Clin (Barc)"},{"issue":"Suppl 3","key":"8271_CR7","doi-asserted-by":"publisher","first-page":"528","DOI":"10.31138\/mjr.270924.poa","volume":"35","author":"A Angelopoulos","year":"2024","unstructured":"Angelopoulos A, Kouverianos I, Daoussis D (2024) The paradox of osteoporosis in spondyloarthropathies. Mediterr J Rheumatol 35(Suppl 3):528","journal-title":"Mediterr J Rheumatol"},{"key":"8271_CR8","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X20969260","volume":"12","author":"G Clunie","year":"2020","unstructured":"Clunie G, Horwood N (2020) Loss and gain of bone in spondyloarthritis: what drives these opposing clinical features? Ther Adv Musculoskelet Dis 12:1759720x20969260","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"8271_CR9","volume-title":"Pathogenesis, assessment, and management of bone loss in axial spondyloarthritis","year":"2024","unstructured":"Nakamura A, Towheed T (eds) (2024) Pathogenesis, assessment, and management of bone loss in axial spondyloarthritis. Elsevier"},{"issue":"6","key":"8271_CR10","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1093\/rheumatology\/keaf090","volume":"64","author":"SS Zhao","year":"2025","unstructured":"Zhao SS, Harrison SR, Thompson B, Yates M, Eddison J, Chan A et al (2025) Executive summary: the 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs. Rheumatology (Oxford) 64(6):3234\u20133241","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"8271_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/ard-2022-223296","volume":"82","author":"S Ramiro","year":"2022","unstructured":"Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos X et al (2022) ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis 82(1):19\u201334","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"8271_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.semarthrit.2014.05.008","volume":"44","author":"NN Haroon","year":"2014","unstructured":"Haroon NN, Sriganthan J, Al Ghanim N, Inman RD, Cheung AM (2014) Effect of TNF-alpha inhibitor treatment on bone mineral density in patients with ankylosing spondylitis: a systematic review and meta-analysis. Semin Arthritis Rheum 44(2):155\u2013161","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"8271_CR13","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/art.43082","volume":"77","author":"D Driscoll","year":"2025","unstructured":"Driscoll D, George N, Peloquin C, Jafarzadeh S, Liew J, Dubreuil M (2025) Association of therapies for axial spondyloarthritis on the risk of hip and spine fractures. Arthritis Rheumatol 77(6):677\u2013685","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"8271_CR14","first-page":"830","volume":"32","author":"F Maas","year":"2014","unstructured":"Maas F, Spoorenberg A, Brouwer E, Bos R, Chaudhry R, Wink F et al (2014) Development of new radiographic vertebral fractures in patients with ankylosing spondylitis during 4 years of TNF-\u03b1 blocking therapy. Clin Exp Rheumatol 32(5):830\u2013831","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"8271_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016548","volume":"7","author":"Y Robinson","year":"2017","unstructured":"Robinson Y, Olerud C, Willander J (2017) Do biological disease-modifying antirheumatic drugs reduce the spinal fracture risk related to ankylosing spondylitis? A longitudinal multiregistry matched cohort study. BMJ Open 7(12):e016548","journal-title":"BMJ Open"},{"key":"8271_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2147\/BTT.S434318","volume":"17","author":"M Siderius","year":"2023","unstructured":"Siderius M, Kieskamp S, Wink F, Kroese FGM, Arends S, Spoorenberg A (2023) The effect of two years of secukinumab treatment on bone metabolism in patients with radiographic axial spondyloarthritis: results from daily clinical practice. Biol Targets Ther 17:161\u20136","journal-title":"Biol Targets Ther"},{"key":"8271_CR17","doi-asserted-by":"crossref","unstructured":"Heiting C, McMahon D, Mintz D, Russell L, Ashany D, Yuan W et al (2025) Effects of secukinumab on skeletal microarchitecture and vertebral fractures in patients with axial spondyloarthritis using HR-pQCT. Arch Osteoporos 20(1)","DOI":"10.1007\/s11657-025-01565-w"},{"issue":"4","key":"8271_CR18","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3899\/jrheum.150857","volume":"43","author":"M van der Weijden","year":"2016","unstructured":"van der Weijden M, van Denderen J, Lems W, Nurmohamed M, Dijkmans B, van der Horst-Bruinsma I (2016) Etanercept increases bone mineral density in ankylosing spondylitis, but does not prevent vertebral fractures: results of a prospective observational cohort study. J Rheumatol 43(4):758\u2013764","journal-title":"J Rheumatol"},{"key":"8271_CR19","doi-asserted-by":"crossref","unstructured":"Kang KY, Kim IJ, Jung SM, Kwok SK, Ju JH, Park KS et al (2014) Incidence and predictors of morphometric vertebral fractures in patients with ankylosing spondylitis. Arthritis Res Ther 16(3)","DOI":"10.1186\/ar4581"},{"issue":"6","key":"8271_CR20","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1002\/jbmr.3684","volume":"34","author":"K Beek","year":"2019","unstructured":"Beek K, Rusman T, van der Weijden M, Lems W, van Denderen J, Konsta M et al (2019) Long-term treatment with TNF-alpha inhibitors improves bone mineral density but not vertebral fracture progression in ankylosing spondylitis. J Bone Miner Res 34(6):1041\u20138","journal-title":"J Bone Miner Res"},{"issue":"1","key":"8271_CR21","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/mr\/roae048","volume":"35","author":"K Kai","year":"2024","unstructured":"Kai K, Fujiwara T, Akasaki Y, Tsushima H, Hara D, Arisumi S et al (2024) Risk factor analysis of vertebral fractures requiring surgery in patients with ankylosing spondylitis. Mod Rheumatol 35(1):162\u20136","journal-title":"Mod Rheumatol"},{"issue":"7","key":"8271_CR22","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/1756-185X.14076","volume":"24","author":"J Huang","year":"2021","unstructured":"Huang J, Zhang L, Wei JC-C (2021) Interleukin-17 inhibitor, is it safer than tumor necrosis factor inhibitor? Int J Rheum Dis 24(7):865\u2013868","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"8271_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102760","volume":"20","author":"SS Groen","year":"2021","unstructured":"Groen SS, Sinkeviciute D, Bay-Jensen AC, Thudium CS, Karsdal MA, Thomsen SF et al (2021) Exploring IL-17 in spondyloarthritis for development of novel treatments and biomarkers. Autoimmun Rev 20(3):102760","journal-title":"Autoimmun Rev"},{"issue":"5","key":"8271_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-019-0818-9","volume":"21","author":"D Ashany","year":"2019","unstructured":"Ashany D, Stein EM, Goto R, Goodman SM (2019) The effect of TNF inhibition on bone density and fracture risk and of IL17 inhibition on radiographic progression and bone density in patients with axial spondyloarthritis: a systematic literature review. Curr Rheumatol Rep 21(5):20","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"8271_CR25","first-page":"191","volume":"34","author":"F Maas","year":"2016","unstructured":"Maas F, Spoorenberg A, Brouwer E, Schilder AM, Chaudhry RN, Wink F et al (2016) Radiographic vertebral fractures develop in patients with ankylosing spondylitis during 4 years of TNF-\u03b1 blocking therapy. Clin Exp Rheumatol 34(2):191\u2013199","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"8271_CR26","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/rheumatology\/ket385","volume":"53","author":"G Akg\u00f6l","year":"2013","unstructured":"Akg\u00f6l G, Kamanl\u0131 A, Ozgocmen S (2013) Evidence for inflammation-induced bone loss in non-radiographic axial spondyloarthritis. Rheumatology 53(3):497\u2013501","journal-title":"Rheumatology"},{"key":"8271_CR27","doi-asserted-by":"publisher","first-page":"569449","DOI":"10.3389\/fmed.2020.569449","volume":"7","author":"MJ Lim","year":"2020","unstructured":"Lim MJ, Kang KY (2020) A contemporary view of the diagnosis of osteoporosis in patients with axial spondyloarthritis. Front Med 7:569449. https:\/\/doi.org\/10.3389\/fmed.2020.569449","journal-title":"Front Med"},{"key":"8271_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/medsci13030189","author":"EG Alvarez-Ayala","year":"2025","unstructured":"Alvarez-Ayala EG, Gamez-Nava JI, Salda\u00f1a-Cruz AM, Gonzalez-Ponce F, Contreras-Haro B, Ramirez-Villafa\u00f1a M et al (2025) Bone mineral density and serum levels of bone remodeling markers in ankylosing spondylitis treated with anti TNF-\u03b1 agents. Med Sci (Basel). https:\/\/doi.org\/10.3390\/medsci13030189","journal-title":"Med Sci (Basel)"},{"issue":"1","key":"8271_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S2213-8587(13)70045-7","volume":"1","author":"MJ Seibel","year":"2013","unstructured":"Seibel MJ, Cooper MS, Zhou H (2013) Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives. Lancet Diabetes Endocrinol 1(1):59\u201370","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"8271_CR30","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41584-023-01034-z","volume":"19","author":"W Bautista-Molano","year":"2023","unstructured":"Bautista-Molano W, Fern\u00e1ndez-\u00c1vila DG, Brance ML, \u00c1vila Pedretti MG, Burgos-Vargas R, Corbacho I et al (2023) Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis. Nat Rev Rheumatol 19(11):724\u2013737","journal-title":"Nat Rev Rheumatol"},{"key":"8271_CR31","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheum.2025.24046","author":"A Kumar Agrawal","year":"2025","unstructured":"Kumar Agrawal A, Rath PD, Chouhan S, Bisaralli R, Kalyani H, Bhagawati J (2025) Assessment of glucocorticoid-induced osteoporosis treatment by prevailing guidelines in a tertiary care hospital. Eur J Rheumatol. https:\/\/doi.org\/10.5152\/eurjrheum.2025.24046","journal-title":"Eur J Rheumatol"},{"issue":"11","key":"8271_CR32","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1590\/S1807-59322010001100024","volume":"65","author":"RM Pereira","year":"2010","unstructured":"Pereira RM, Carvalho JF, Canalis E (2010) Glucocorticoid-induced osteoporosis in rheumatic diseases. Clinics (Sao Paulo) 65(11):1197\u20131205","journal-title":"Clinics (Sao Paulo)"},{"issue":"2","key":"8271_CR33","doi-asserted-by":"publisher","first-page":"298","DOI":"10.5312\/wjo.v6.i2.298","volume":"6","author":"E Kilic","year":"2015","unstructured":"Kilic E, Ozgocmen S (2015) Bone mass in axial spondyloarthritis: a literature review. World J Orthop 6(2):298\u2013310","journal-title":"World J Orthop"},{"issue":"1","key":"8271_CR34","first-page":"150484","volume":"2011","author":"SB Chaudhary","year":"2011","unstructured":"Chaudhary SB, Hullinger H, Vives MJ (2011) Management of acute spinal fractures in ankylosing spondylitis. Int Sch Res Not 2011(1):150484","journal-title":"Int Sch Res Not"},{"issue":"2 Suppl","key":"8271_CR35","doi-asserted-by":"publisher","first-page":"56s","DOI":"10.1177\/2192568217736268","volume":"8","author":"M Reinhold","year":"2018","unstructured":"Reinhold M, Knop C, Kneitz C, Disch A (2018) Spine fractures in ankylosing diseases: recommendations of the spine section of the German Society for Orthopaedics and Trauma (DGOU). Glob Spine J 8(2 Suppl):56s\u201368s","journal-title":"Glob Spine J"},{"issue":"1","key":"8271_CR36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12873-022-00635-3","volume":"22","author":"PH Tu","year":"2022","unstructured":"Tu PH, Liu ZH, Yeap MC, Liu YT, Li YC, Huang YC et al (2022) Spinal cord injury and spinal fracture in patients with ankylosing spondylitis. BMC Emerg Med 22(1):73","journal-title":"BMC Emerg Med"},{"key":"8271_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2023.152345","volume":"64","author":"A Nakamura","year":"2024","unstructured":"Nakamura A, Towheed T (2024) Pathogenesis, assessment, and management of bone loss in axial spondyloarthritis. Semin Arthritis Rheum 64:152345","journal-title":"Semin Arthritis Rheum"},{"key":"8271_CR38","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002302","author":"Z Li","year":"2022","unstructured":"Li Z, van der Linden SM, Khan MA, Baumberger H, Zandwijk HV, Khan MK et al (2022) Heterogeneity of axial spondyloarthritis: genetics, sex and structural damage matter. RMD Open. https:\/\/doi.org\/10.1136\/rmdopen-2022-002302","journal-title":"RMD Open"},{"issue":"10","key":"8271_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103638","volume":"23","author":"F Proft","year":"2024","unstructured":"Proft F, Duran TI, Ghoreschi K, Pleyer U, Siegmund B, Poddubnyy D (2024) Treatment strategies for spondyloarthritis: implementation of precision medicine - or \u201cone size fits all\u201d concept? Autoimmun Rev 23(10):103638","journal-title":"Autoimmun Rev"},{"key":"8271_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2024.152523","volume":"68","author":"M Siderius","year":"2024","unstructured":"Siderius M, Wink F, Kieskamp S, Maas F, Bos R, Kroese FGM et al (2024) Improvement of bone mineral density and new vertebral fractures during 8 years of TNF-\u03b1 inhibition in patients with axial spondyloarthritis. Semin Arthritis Rheum 68:152523","journal-title":"Semin Arthritis Rheum"},{"issue":"605","key":"8271_CR41","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3399\/bjgp12X659475","volume":"62","author":"N O\u2019Flynn","year":"2012","unstructured":"O\u2019Flynn N (2012) Risk assessment of fragility fracture: NICE guideline. Br J Gen Pract 62(605):667\u2013668","journal-title":"Br J Gen Pract"},{"issue":"3","key":"8271_CR42","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/rheumatology\/kex377","volume":"57","author":"KY Kang","year":"2017","unstructured":"Kang KY, Goo H, Park S-H, Hong YS (2017) Trabecular bone score as an assessment tool to identify the risk of osteoporosis in axial spondyloarthritis: a case\u2013control study. Rheumatology Oxf 57(3):462\u2013469","journal-title":"Rheumatology Oxf"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08271-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08271-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08271-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T08:35:34Z","timestamp":1787992534000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08271-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["8271"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08271-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}